Copyright
©The Author(s) 2022.
World J Transplant. Oct 18, 2022; 12(10): 313-324
Published online Oct 18, 2022. doi: 10.5500/wjt.v12.i10.313
Published online Oct 18, 2022. doi: 10.5500/wjt.v12.i10.313
Figure 1 Sequential changes.
A: Total lymphocyte populations; B: CD4 cells; C: CD8 cells. Differences between panel reactive antibody (PRA)(-) and PRA(+) patients. aP < 0.001 vs T0; bP = 0.003 vs T0; cP < 0.001 vs T0; dP = 0.006 vs T0; eP < 0.001 vs T0; fP = 0.003 vs T0; gP = 0.03 vs T0.
Figure 2 Changes in the number of CD4CD28null and CD8CD28null cells during follow up in panel reactive antibody patients.
A: CD4CD28null cells; B: CD8CD28null cells.
Figure 3 Changes in natural killer cells and regulatory T cells during follow-up in panel reactive antibody (-) and panel reactive antibody (+) patients.
A: Natural killer cells; B: Regulatory T cells. aP = 0.002 vs T0; bP = 0.005 vs T3; cP = 0.01 vs T0; dP = 0.003 vs T3; eP = 0.04 vs T3. PRA: Panel reactive antibody.
- Citation: Vagiotas L, Stangou M, Kasimatis E, Xochelli A, Myserlis G, Lioulios G, Nikolaidou V, Panteli M, Ouranos K, Antoniadis N, Maria D, Papagianni A, Tsoulfas G, Fylaktou A. Effect of panel reactive antibodies on T cell immunity reinstatement following renal transplantation. World J Transplant 2022; 12(10): 313-324
- URL: https://www.wjgnet.com/2220-3230/full/v12/i10/313.htm
- DOI: https://dx.doi.org/10.5500/wjt.v12.i10.313